Jasper Therapeutics Inc [NASDAQ: JSPR] stock went on a downward path that fall over -60.53% on Wednesday, amounting to a one-week price decrease of less than -67.31%.
Over the last 12 months, JSPR stock dropped by -0.14%. The one-year Jasper Therapeutics Inc stock forecast points to a potential upside of 88.67. The average equity rating for JSPR stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $104.86 million, with 15.00 million shares outstanding and 11.24 million shares in the current float. Compared to the average trading volume of 281.61K shares, JSPR stock reached a trading volume of 6563586 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Jasper Therapeutics Inc [JSPR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JSPR shares is $61.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JSPR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BMO Capital Markets have made an estimate for Jasper Therapeutics Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on December 06, 2024. While these analysts kept the previous recommendation, JMP Securities raised their target price to Mkt Outperform. The new note on the price target was released on September 09, 2024, representing the official price target for Jasper Therapeutics Inc stock. Previously, the target price had yet another raise to $90, while BTIG Research analysts kept a Buy rating on JSPR stock.
The Average True Range (ATR) for Jasper Therapeutics Inc is set at 2.56 The Price to Book ratio for the last quarter was 1.25, with the Price to Cash per share for the same quarter was set at 6.17.
JSPR Stock Performance Analysis:
Jasper Therapeutics Inc [JSPR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -67.31. With this latest performance, JSPR shares dropped by -68.91% in over the last four-week period, additionally sinking by -64.82% over the last 6 months – not to mention a drop of -0.14% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for JSPR stock in for the last two-week period is set at 19.23, with the RSI for the last a single of trading hit 14.24, and the three-weeks RSI is set at 23.88 for Jasper Therapeutics Inc [JSPR]. The present Moving Average for the last 50 days of trading for this stock 21.65, while it was recorded at 17.19 for the last single week of trading, and 21.59 for the last 200 days.
Insight into Jasper Therapeutics Inc Fundamentals:
Jasper Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.61 and a Current Ratio set at 7.61.
Jasper Therapeutics Inc [JSPR] Institutonal Ownership Details
There are presently around $98.74%, or 100.02%% of JSPR stock, in the hands of institutional investors.
